10-Q: Optex Systems Reports Strong Q3 Earnings Growth

Sentiment:

Quarterly Report 12 August 2025 7:01 AM

📋All filings for Optex Systems Holdings INC

Optex Systems Holdings, Inc. announced significant revenue and net income increases for the third quarter and first nine months of fiscal year 2025, driven by increased customer demand.

Delay expectedDelays in key components and labor shortages during the first half of fiscal year 2024 negatively impacted production levels and pushed expected delivery dates for periscope products into fiscal year 2025.The company cannot give assurances that expected customer delivery dates for periscope products will not experience further delays.There were delays in the Speedtracker product line launch during the twelve months ended September 29, 2024.

Better than expectedNet income increased by 19.7% for the three months and 49.7% for the nine months ended June 29, 2025, indicating strong profitability.Revenue grew by 22.6% for the three months and 22.3% for the nine months, demonstrating robust top-line performance.Operating income showed significant growth of 18.3% for the three months and 43.8% for the nine months, reflecting improved operational efficiency.Cash flow from operating activities increased substantially to $5.37 million for the nine-month period, indicating strong cash generation from core operations.

Summary

Revenue for the three months ended June 29, 2025, increased by $2.1 million (22.6%) to $11.11 million, compared to $9.06 million in the prior year period.
Net income for the three months ended June 29, 2025, rose by $0.2 million (19.7%) to $1.51 million, up from $1.26 million in the prior year period.
For the nine months ended June 29, 2025, total revenues increased by $5.5 million (22.3%) to $30.04 million, compared to $24.55 million in the prior year period.
Net income for the nine months ended June 29, 2025, grew by $1.3 million (49.7%) to $4.12 million, from $2.75 million in the prior year period.
Adjusted EBITDA increased by $0.3 million to $2.13 million for the three months and by $1.5 million to $5.70 million for the nine months ended June 29, 2025.
Net cash provided by operating activities for the nine months ended June 29, 2025, was $5.37 million, a substantial increase from $1.03 million in the prior year period.
New orders for the nine months ended June 29, 2025, decreased by 14.8% to $24.1 million, with Optex Richardson segment orders decreasing by 43.2%.
Backlog as of June 29, 2025, was $38.3 million, a 16.0% decrease from $45.6 million as of June 30, 2024.
The company's credit facility with Texas Capital Bank was renewed for $3 million, with a zero outstanding balance as of June 29, 2025.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial performance with significant increases in revenue, net income, and operating cash flow, indicating robust operational execution. The renewal of the credit facility and recent new contract awards are positive indicators. However, the decline in new orders and backlog, coupled with increased contract loss reserves due to inflationary pressures and labor inefficiencies on older fixed-price contracts, temper the overall positive outlook.

Positives

Revenue increased significantly by 22.6% for the quarter and 22.3% for the nine-month period, indicating strong customer demand.
Net income saw substantial growth, rising 19.7% for the quarter and 49.7% for the nine-month period.
Operating income increased by 18.3% for the quarter and 43.8% for the nine-month period, reflecting improved operational efficiency.
Cash generated from operating activities was robust, reaching $5.37 million for the nine-month period, a significant improvement from the prior year.
Periscope production levels increased by 74% over the corresponding nine-month period in fiscal year 2024.
Improvements in supplier performance and labor availability for the Optex Richardson segment were noted.
The company successfully renewed its $3 million revolving credit facility with Texas Capital Bank, with a zero outstanding balance.
Recent new orders include a $2.8 million order for the XM30 combat vehicle and a five-year contract for Abrams-based optical sighting systems.

Negatives

Overall new orders decreased by 14.8% to $24.1 million for the nine months ended June 29, 2025.
The Optex Richardson segment experienced a significant 43.2% decrease in new orders.
Total backlog decreased by 16.0% to $38.3 million as of June 29, 2025, compared to the prior year period.
Gross margin percentage decreased to 28.5% for the quarter (from 31.8%) and 28.8% for the nine months (from 29.0%), primarily due to shifts in revenue between segments and product groups.
Contract loss reserves increased to $423 thousand as of June 29, 2025, due to inflationary pressures on material and labor, and increased manufacturing overhead costs on older fixed-price contracts.
Estimated loss reserves increased due to higher rework and labor inefficiencies as the company ramped up production and trained new employees on the periscope line.
The Applied Optics Center segment experienced lower customer demand for optical assemblies, partially offsetting gains in other product lines.
Delays in the Speedtracker product line launch occurred during the twelve months ended September 29, 2024.

Risks

Continued funding of defense programs and military spending, and the timing of such funding, can impact business.
General economic and business conditions, including unforeseen weakness in the company's markets, pose risks.
Effects of continued geopolitical unrest and regional conflicts could impact operations.
Competition and changes in technology and marketing methods may affect market position.
Delays in completing engineering and manufacturing programs could impact delivery schedules and revenue.
Changes in customer order patterns and product mix can affect financial results.
Changes in the U.S. Government's interpretation of federal procurement rules and regulations may impact contracts.
Changes in spending due to policy changes in any new federal presidential administration could affect demand.
Market acceptance of the company's products is crucial for sustained growth.
Shortages in components and production delays due to performance quality issues with outsourced components remain a concern.
Inability to fully realize expected benefits from acquisitions and restructurings or delays in realizing such benefits could occur.
Challenges in integrating acquired businesses and achieving anticipated synergies may arise.
Changes to export regulations could impact foreign military sales.
Increases in tax rates and changes to generally accepted accounting principles may affect financial reporting.
Difficulties in retaining key employees and customers could impact operations and relationships.
Unanticipated costs under fixed-price service and system integration engagements could erode profitability.
Changes in the market for microcap stocks, regardless of growth and value, may affect share price.
Inflationary pressures on material and labor, combined with increased manufacturing overhead costs, continue to negatively affect margins on long-term fixed-price contracts.
There is no assurance that expected customer delivery dates for periscope products will not experience further delays.
A potential warranty issue on Applied Optics Day Windows could lead to increased costs.
Uncertainties of future income forecasts combined with the complexity of some deferred tax assets may impact estimated reserves in future periods.

Future Outlook

The company anticipates additional orders in the coming months, including an initial year task award against a new Abrams contract within the fiscal year. It expects the trend of increased demand for military filters and day windows, offset by lower demand for commercial optical assemblies, to continue into the first half of fiscal year 2026. Management plans to utilize current cash, available credit, and operating cash flow to fund inventory purchases for backlog growth and higher anticipated revenue over the next twelve months. Excess short-term cash may be used for product line purchases and stock repurchases, while longer-term excess cash could fund new product development, acquisitions, or additional stock purchases. The company expects to generate net income and positive cash flow from operating activities over the next twelve months.

Management Comments

We have seen improvements in the local labor market since 2023 and increased our direct labor force and employee overtime in concert with improvements in our supplier delivery performance.
While we are encouraged by improvements in supplier performance and available manpower for the Optex Richardson segment periscope line which yielded increased revenue performance during fiscal year 2024 and 2025, we have yet to ramp up deliveries sufficiently to keep pace with our current customer demands.
The Company continues to aggressively pursue international and commercial opportunities in addition to maintaining its current footprint with U.S. vehicle manufactures, with existing as well as new product lines.
We are also reviewing potential products, outside our traditional product lines, which could be manufactured using our current production facilities in order to capitalize on our existing excess capacity.

Industry Context

Optex Systems Holdings operates primarily within the U.S. defense sector, manufacturing optical sighting systems for military applications. The company's performance is directly influenced by U.S. government military spending, particularly for ground system military programs, which have seen significant reductions. The company's reliance on major U.S. defense contractors and direct government contracts means it is subject to Federal Acquisition Regulation. While the company has seen increased demand in certain military product lines, the broader industry context includes geopolitical unrest and regional conflicts, which are noted as general risk factors.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
President	N/A (newly created position)	Chad George	2025-08-11	Appointment to a newly created position, allowing the offices of Chief Executive Officer and President to be held by different individuals.
Chairman and Chief Executive Officer	N/A (continuing role)	Danny Schoening	2025-08-11	Continues in role following the creation of a separate President position.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Bylaws Amendment	Amended Bylaws to create a new Chief Executive Officer position (allowing CEO and President to be separate roles, with CEO as principal executive officer), add deadlines and procedural requirements for shareholder proposals and director nominations, add a new article for indemnification of directors and officers, and add a forum selection clause.	2025-08-10	Enhances corporate structure by formally separating key executive roles, clarifies and formalizes shareholder engagement processes, strengthens protections for directors and officers, and establishes a clear legal forum for disputes.
Committee Charter Amendments	Approved amendments of the charters of the Nominating and Corporate Governance Committee, Audit Committee, and Compensation Committee.	2025-08-11	Likely to refine the responsibilities, scope, and operational procedures of key board committees, potentially improving corporate oversight, governance practices, and alignment with best practices.

Stakeholder Impact

Shareholders: Positive financial results (revenue, net income, EPS, cash flow) could enhance shareholder value. The stock repurchase plan may also benefit shareholders. However, the decrease in new orders and backlog, along with increased contract loss reserves, could be areas of concern.
Employees: The increase in direct labor force and employee overtime, along with the appointment of a new President and ongoing equity incentive plans, indicates continued investment in human capital. However, some employees experienced forfeiture of restricted stock units upon resignation.
Customers: Increased production levels and improved supplier performance are aimed at meeting customer demands. However, past periscope delivery delays and increased contract loss reserves on older fixed-price contracts due to cost pressures could impact customer satisfaction or future pricing.
Suppliers: The company noted improvements in supplier delivery performance, suggesting stable relationships and operational efficiency.
Creditors: The company's zero outstanding balance on its renewed credit facility and strong cash position reduce credit risk, benefiting creditors.

Next Steps

Continue to ramp up deliveries sufficiently to keep pace with current customer demands for periscope products.
Aggressively pursue international and commercial opportunities.
Maintain current footprint with U.S. vehicle manufacturers, utilizing existing and new product lines.
Review potential products, outside traditional product lines, that could be manufactured using current production facilities to capitalize on existing excess capacity.
Anticipate additional capital projects forthcoming in the next six months.
Anticipate the initial year task award against the new Abrams contract within the fiscal year.
Continue to monitor the recoverability of the Speedtracker asset as the product launched in April 2025 and is in current production.

Key Dates

Date	Description
2018-10-01	Commencement date of a non-cancellable office equipment lease.
2020-04-30	Board of Directors voted to increase annual board compensation for three independent directors and granted 300,000 shares of restricted stock.
2021-01-11	Company executed a sixth amendment extending the Optex Richardson facility lease terms.
2021-01-11	Company executed a first amendment extending the Applied Optics Center Dallas facility lease terms.
2021-04-01	Commencement of the extended Optex Richardson facility lease term.
2021-11-01	Commencement of the extended Applied Optics Center Dallas facility lease term.
2021-11-18	Office equipment lease renewed for an additional 48 months.
2022-01-01	Initial base rent for Applied Optics Center Dallas facility lease set at $23.6 thousand.
2023-02-16	40,000 unvested restricted shares were forfeited and cancelled when an independent director departed the Board.
2023-03-22	Company entered into a Business Loan Agreement with Texas Capital Bank for a $3 million revolving line of credit.
2023-05-01	Company granted an aggregate of 39,000 restricted stock units to eleven employees under its 2023 Equity Incentive Plan.
2023-05-03	Board of Directors approved a grant of 100,000 and 35,000 performance shares to Danny Schoening (CEO) and Karen Hawkins (CFO), respectively.
2023-05-09	Board of Directors approved a grant of 40,000 shares of restricted stock to independent board member Dayton Judd.
2023-08-14	Additional grant of 3,000 restricted stock units to one new employee.
2023-10-02	27,000 performance shares vested for Tranche 1.
2023-10-24	Company issued 21,060 shares in settlement of the vested Tranche 1 performance shares.
2023-12-22	27,000 performance shares vested for Tranche 2.
2023-12-29	27,000 performance shares vested for Tranche 3.
2024-01-08	Company issued 39,563 shares in settlement of the vested Tranche 2 and Tranche 3 performance shares.
2024-01-18	Company acquired certain intellectual property and technical/marketing information relating to the Speedtracker Mach product line.
2024-03-11	27,000 performance shares vested for Tranche 4.
2024-03-13	Company issued 20,669 shares in settlement of the vested Tranche 4 performance shares.
2024-05-01	Company granted an aggregate of 39,000 restricted stock units to eleven employees under its 2023 Equity Incentive Plan.
2024-05-01	12,000 shares vested under the 2023 Equity Incentive Plan for restricted stock units granted on May 1, 2023.
2024-05-03	8,446 shares were issued to ten employees, net of tax withheld, for vested restricted stock units.
2024-05-17	27,000 performance shares vested for Tranche 5.
2024-05-17	Company issued 20,426 shares in settlement of the vested Tranche 5 performance shares.
2024-06-04	Additional grant of 500 restricted stock units to one employee.
2024-07-03	Additional grant of 1,000 restricted stock units to one employee.
2024-08-14	1,000 shares vested under the 2023 Equity Incentive Plan for restricted stock units granted on August 14, 2023.
2024-08-20	704 shares were issued to one employee, net of tax withheld, for vested restricted stock units.
2024-09-29	Fiscal year end for 2024.
2024-11-05	Board of Directors approved new board compensation for the three independent directors, including 22,800 shares of restricted stock.
2024-12-29	7,500 restricted stock units forfeited due to the resignation of two employees.
2025-01-01	60,000 restricted shares vested.
2025-05-01	23,000 shares vested under the 2023 Equity Incentive Plan for restricted stock units granted on May 1, 2023, and May 1, 2024.
2025-05-01	Company granted an aggregate of 39,000 restricted stock units to eleven employees under its 2023 Equity Incentive Plan.
2025-05-21	Company and Optex renewed their existing credit facility with Texas Capital Bank.
2025-05-22	Effective date of the new Business Loan Agreement with Texas Capital Bank; commitment period for advances under the previous facility expired.
2025-06-29	End of the current reporting period (Q3 fiscal year 2025).
2025-07-07	Company announced a $2.8 million order from a major prime contractor in support of the XM30 combat vehicle.
2025-07-22	Company announced the award of a five-year requirement-type contract by the Army Contracting Command for Abrams based optical sighting systems.
2025-08-10	Board of Directors amended the company's Bylaws to create a new Chief Executive Officer position, add shareholder procedural requirements, provide for indemnification, and add a forum selection clause.
2025-08-11	Board of Directors appointed Chad George as the company's new President.
2025-08-11	Board of Directors approved amendments of the charters of the Nominating and Corporate Governance Committee, Audit Committee, and Compensation Committee.
2025-08-12	Date of the 10-Q filing.
2026-01-01	Vesting date for restricted stock granted to independent directors on November 5, 2024, and to Chad George on August 11, 2025.
2026-02-01	Potential extension of delivery period for one long-term contract.
2027-05-22	Maturity Date of the renewed Texas Capital Facility.
2028-05-31	End of the Optex Richardson facility lease term.
2028-12-31	End of the Applied Optics Center Dallas facility lease term.

Recommendation

buy

Optex Systems Holdings, Inc. demonstrates strong financial performance with significant year-over-year increases in revenue, net income, and operating cash flow. The company's core business in defense optical systems is robust, supported by recent contract awards and efforts to increase production capacity. While there are concerns regarding declining new orders and backlog, and increased contract loss reserves on older fixed-price contracts due to inflationary pressures, the overall operational improvements, strong cash generation, and strategic initiatives to diversify and optimize production suggest a positive trajectory. The renewed credit facility and healthy cash balance provide financial flexibility. The management changes also indicate a focus on strengthening leadership for future growth. Given the strong profitability and cash flow, the stock appears to be a compelling 'buy' for investors looking for exposure to the defense sector with a company showing operational momentum.

Keywords

Optical Sighting Systems, Defense Contractor, Military Vehicles, Periscopes, Night Vision, Laser Filters, US Government Contracts, Aerospace & Defense, Precision Optics, SEC Filing, 10-Q, Financial Report, Quarterly Earnings, Optex Systems

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.